Xellia Pharmaceuticals
A Specialist in Global Regulatory Affairs API handles global regulatory life cycle activities related to APIs manufactured by Xellia, including assessment of change controls, documentation support, and communication with regulatory authorities.
Headquarters
Copenhagen, Hovedstaden, Denmark
Company Size
1001-5000 employees
Founded
1903
Xellia Pharmaceuticals is a global leader in fermentation-based non-beta-lactam anti-infectives, supplying APIs and finished dosage forms to more than 500 pharmaceutical companies across 80 countries. With over 120 years of experience, the company focuses on reliable, uninterrupted supply of critical anti-infective medicines. Headquartered in Copenhagen, Denmark, Xellia is one of the last Western manufacturers of several essential anti-infective APIs.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Xellia Pharmaceuticals.
Xellia Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
Biosimilars Regulatory Affairs Manager
Zentiva Česká republika
Director, Global Regulatory Affairs
Cardinal Health
Regulatory Affairs Responsible, External Manufacturing API
Opella
Director, Global CMC Regulatory
Revolution Medicines
Regulatory Affairs Specialist
GovernmentJobs
Regulatory Affairs Lead
gloorlang